BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16455621)

  • 21. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis.
    Kitawaki J; Koshiba H; Kitaoka Y; Teramoto M; Hasegawa G; Nakamura N; Yoshikawa T; Ohta M; Obayashi H; Honjo H
    Hum Reprod; 2004 Aug; 19(8):1765-9. PubMed ID: 15166131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
    Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
    Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
    Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing.
    Wieser F; Fabjani G; Tempfer C; Schneeberger C; Sator M; Huber J; Wenzl R
    J Soc Gynecol Investig; 2003 Jan; 10(1):32-6. PubMed ID: 12517591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
    Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
    Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
    Gai X; Lan X; Luo Z; Wang F; Liang Y; Zhang H; Zhang W; Hou J; Huang M
    Clin Chim Acta; 2009 Oct; 408(1-2):105-9. PubMed ID: 19665460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocyte stimulator -817C>T promoter polymorphism and the predisposition for the development of deep infiltrating endometriosis.
    de Graaff AA; Dunselman GA; Delvoux B; van Kaam KJ; Smits LJ; Romano A
    Fertil Steril; 2010 Aug; 94(3):1108-10. PubMed ID: 20004378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
    Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of functional polymorphisms on MMP-12 and MMP-13 gene promoter region with epithelial ovarian carcinoma].
    Jia J; Kang S; Zhao J; Zhang X; Wang N; Zhou R; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):209-13. PubMed ID: 20376807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
    Ye H; He Y; Wang J; Song T; Lan Z; Zhao Y; Xi M
    J Genet; 2016 Sep; 95(3):611-9. PubMed ID: 27659332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women.
    Liu Q; Li Y; Zhao J; Sun DL; Duan YN; Wang N; Zhou RM; Kang S
    Hum Reprod; 2009 Oct; 24(10):2660-6. PubMed ID: 19531502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
    Koh YS; Chang K; Kim PJ; Seung KB; Baek SH; Shin WS; Lim SH; Kim JH; Choi KB
    Int J Cardiol; 2008 Jul; 127(3):430-2. PubMed ID: 17698228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.